Diagnos Laboratorium Utama Tbk. vs Surya Pertiwi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Surya Pertiwi Tbk. trades at Rp590 (market cap 1.58T, 783.8K 24h volume). The key difference: Surya Pertiwi Tbk. is far larger — about 5.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 783.8K). Which is the better fit depends on your goals.
| DGNS | SPTO | |
|---|---|---|
Market Cap | 310.75B | 1.58T |
Volume | 963.6K | 783.8K |
Lot | 9.64K | 7.84K |
Turnover | 217.67M | 456.89M |
Average Price | 225.89 | 582.91 |
Value | 217.67M | 456.89M |
Indicative Equilibrium Price | 226 | 590 |
Indicative Equilibrium Volume | 1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Surya Pertiwi Tbk (the Company) formerly PT Surya Nusantara was established in the Republic of Indonesia on July 5, 1978 and was published in State Gazette No. 172, Supplement No. 31 dated April 17, 1979 based on Notarial Deed No. 1 of Hendra Karyadi, S.H.
Read more on SPTO →